MedPath

Investigations on the Effect of Kale on the Lipid Status

Not Applicable
Conditions
Effects of Kale Ingredients on Lipid Status Parameter
Interventions
Dietary Supplement: Kale Preparation "Kale Powder"
Dietary Supplement: Kale Preparation "Kale Extract"
Dietary Supplement: Kale Preparation "Flavonoid Extract"
Dietary Supplement: Placebo
Registration Number
NCT03545555
Lead Sponsor
University of Jena
Brief Summary

This intervention study investigates the effects of various kale preparations (dietary supplements) on lipid status parameters. Within the study period of 8 weeks, three blood withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in blood. There is a correlation between contents of LDL cholesterol, total cholesterol and triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of apolipoprotein A1 and apolipoprotein B will be analysed.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • total cholesterol > 200 mg/dl
Exclusion Criteria
  • LDL cholesterol < 130 mg/dl
  • medication to lower blood lipids
  • genetically based hypercholesterolemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Kale PowderKale Preparation "Kale Powder"5 capsules with kale preparation "kale powder" per day for 8 weeks
Kale ExtractKale Preparation "Kale Extract"5 capsules with kale preparation "kale extract" per day for 8 weeks
Flavonoid ExtractKale Preparation "Flavonoid Extract"5 capsules with kale preparation "flavonoid extract" (from kale) per day for 8 weeks
PlaceboPlacebo5 capsules with "placebo" per day for 8 weeks
Primary Outcome Measures
NameTimeMethod
Change of lipid status parametersweeks 0, 4 and 8

total cholesterol, HDL cholesterol, LDL cholesterol

Secondary Outcome Measures
NameTimeMethod
Change of apolipoproteinsweeks 0, 4 and 8

apolipoprotein A1 and apolipoprotein B

Change of antioxidant capacityweeks 0, 4 and 8

lipophilic antioxidant capacity (L-TEAC)

Trial Locations

Locations (1)

Friedrich Schiller University, Institute iof Nutritional Science

🇩🇪

Jena, Thuringia, Germany

© Copyright 2025. All Rights Reserved by MedPath